Aravali Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.48 M
- Company Age 44 Year, 11 Months
- Last Filing with ROC 31 Mar 2007
- Open Charges ₹ 0.38 M
About Aravali Pharmaceuticals
Aravali Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 March 1980 and has a history of 44 years and 11 months. Its registered office is in Rajastha,, Rajasthan.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2007. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.48 M.
The company currently has active open charges totaling ₹0.38 M.
Pramila Goyal and Rakesh Goyal serve as directors at the Company.
Company Details
- Location Rajastha,, Rajasthan
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ1980PTC002008
- Company No.
002008
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 1980
- Date of AGM
29 Sep 2007
- Date of Balance Sheet
31 Mar 2007
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Aravali Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Goyal  | Managing Director | 29-Jun-1983 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramila Goyal | Director | 11-Apr-1991 | Current |
Financial Performance of Aravali Pharmaceuticals.
Enhance accessibility to Aravali Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aravali Pharmaceuticals?
Unlock access to Aravali Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.38 M
₹0
Charges Breakdown by Lending Institutions
- Central Bank Of India : 0.03 Cr
- Rajasthan Financial Corpn. : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 1983 | Rajasthan Financial Corpn. | ₹0.04 M | Open |
| 17 Feb 1983 | Central Bank Of India | ₹0.20 M | Open |
| 08 Apr 1981 | Central Bank Of India | ₹0.05 M | Open |
| 27 Dec 1980 | Rajasthan Financial Corpn. | ₹0.10 M | Open |
How Many Employees Work at Aravali Pharmaceuticals?
Unlock and access historical data on people associated with Aravali Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aravali Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aravali Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.